Pembrolizumab for recurrent conjunctival melanoma

Ashwini Kini, Roxana Fu, Christopher Compton, Donald M. Miller, Aparna Ramasubramanian

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)891-892
Number of pages2
JournalJAMA Ophthalmology
Volume135
Issue number8
DOIs
StatePublished - Aug 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Kini, A., Fu, R., Compton, C., Miller, D. M., & Ramasubramanian, A. (2017). Pembrolizumab for recurrent conjunctival melanoma. JAMA Ophthalmology, 135(8), 891-892. https://doi.org/10.1001/jamaophthalmol.2017.2279

Pembrolizumab for recurrent conjunctival melanoma. / Kini, Ashwini; Fu, Roxana; Compton, Christopher; Miller, Donald M.; Ramasubramanian, Aparna.

In: JAMA Ophthalmology, Vol. 135, No. 8, 01.08.2017, p. 891-892.

Research output: Contribution to journalShort survey

Kini, A, Fu, R, Compton, C, Miller, DM & Ramasubramanian, A 2017, 'Pembrolizumab for recurrent conjunctival melanoma', JAMA Ophthalmology, vol. 135, no. 8, pp. 891-892. https://doi.org/10.1001/jamaophthalmol.2017.2279
Kini, Ashwini ; Fu, Roxana ; Compton, Christopher ; Miller, Donald M. ; Ramasubramanian, Aparna. / Pembrolizumab for recurrent conjunctival melanoma. In: JAMA Ophthalmology. 2017 ; Vol. 135, No. 8. pp. 891-892.
@article{ec04b3c534a847bfb7ea6764e433332d,
title = "Pembrolizumab for recurrent conjunctival melanoma",
author = "Ashwini Kini and Roxana Fu and Christopher Compton and Miller, {Donald M.} and Aparna Ramasubramanian",
year = "2017",
month = "8",
day = "1",
doi = "10.1001/jamaophthalmol.2017.2279",
language = "English (US)",
volume = "135",
pages = "891--892",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Pembrolizumab for recurrent conjunctival melanoma

AU - Kini, Ashwini

AU - Fu, Roxana

AU - Compton, Christopher

AU - Miller, Donald M.

AU - Ramasubramanian, Aparna

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85027268964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027268964&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2017.2279

DO - 10.1001/jamaophthalmol.2017.2279

M3 - Short survey

C2 - 28715523

AN - SCOPUS:85027268964

VL - 135

SP - 891

EP - 892

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 8

ER -